Takahiro Einama, Yoji Yamagishi, Yasuhiro Takihata, Takafumi Suzuki, Tamio Yamasaki, Yuichi Hirose, . . . Hitoshi Tsuda. (2021). Co-expression of mesothelin and CA125/MUC16 is a prognostic factor for breast cancer, especially in luminal-type breast cancer patients. BMC.
Chicago Style (17th ed.) CitationTakahiro Einama, et al. Co-expression of Mesothelin and CA125/MUC16 Is a Prognostic Factor for Breast Cancer, Especially in Luminal-type Breast Cancer Patients. BMC, 2021.
MLA (9th ed.) CitationTakahiro Einama, et al. Co-expression of Mesothelin and CA125/MUC16 Is a Prognostic Factor for Breast Cancer, Especially in Luminal-type Breast Cancer Patients. BMC, 2021.
Warning: These citations may not always be 100% accurate.